[26] Finkelstein RA,

Boesman-Finkelstein M, Holt P. *Vibrio cholerae* hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F.M. Burnet revisited. Proc Natl Acad Sci U S A. 1983;80(4):1092-1095.

[27] Stauder M, Vezzulli L, Pezzati E, Repetto B, Pruzzo C. Temperature affects *Vibrio cholerae* O1 El Tor persistence in the aquatic environment via an enhanced expression of GbpA and MSHA adhesins. Environ Microbiol Rep. 2010;2(1):140-144.

[28] Mandal S, Chatterjee NS. *Vibrio cholerae* GbpA elicits necrotic cell death in intestinal cells. J Med Microbiol. 2016;65(8):837-847.

[29] Loose JS, Forsberg Z, Fraaije MW, Eijsink VG, Vaaje-Kolstad G. A rapid quantitative activity assay shows that the *Vibrio cholerae* colonization factor GbpA is an active lytic polysaccharide monooxygenase. FEBS Lett. 2014; 588(18):3435-3440.

[30] Garay E, Arnau A, Amaro C. Incidence of *Vibrio cholerae* and related vibrios in a coastal lagoon and seawater influenced by lake discharges along an annual cycle. Appl Environ Microbiol. 1985;50(2):426-430.

[31] Meibom KL, Li XB, Nielsen AT, Wu CY, Roseman S, Schoolnik GK. The *Vibrio cholerae* chitin utilization program. Proc Natl Acad Sci U S A. 2004;101(8):2524-2529.

[32] Bhowmick R, Ghosal A, Chatterjee NS. Effect of environmental factors on expression and activity of chitinase genes of vibrios with special reference to *Vibrio cholerae*. J Appl Microbiol. 2007;103(1):97-108.

*The Secretome of* Vibrio cholerae *DOI: http://dx.doi.org/10.5772/intechopen.96803*

[33] Mondal M, Nag D, Koley H, Saha DR, Chatterjee NS. The *Vibrio cholerae* extracellular chitinase ChiA2 is important for survival and pathogenesis in the host intestine. PLoS One. 2014;9(9):e103119.

[34] Li X, Wang LX, Wang X, Roseman S. The chitin catabolic cascade in the marine bacterium *Vibrio cholerae*: characterization of a unique chitin oligosaccharide deacetylase. Glycobiology. 2007;17(12):1377-1387.

[35] Zhang YZ, Ran LY, Li CY, Chen XL. Diversity, Structures, and Collagen-Degrading Mechanisms of Bacterial Collagenolytic Proteases. Appl Environ Microbiol. 2015;81(18):6098-6107.

[36] Park BR, Zielke RA, Wierzbicki IH, Mitchell KC, Withey JH, Sikora AE. A metalloprotease secreted by the type II secretion system links *Vibrio cholerae* with collagen. J Bacteriol. 2015;197(6): 1051-1064.

[37] Benitez JA, Silva AJ. *Vibrio cholerae* hemagglutinin(HA)/protease: An extracellular metalloprotease with multiple pathogenic activities. Toxicon. 2016;115:55-62.

[38] Zhu J, Miller MB, Vance RE, Dziejman M, Bassler BL, Mekalanos JJ. Quorum-sensing regulators control virulence gene expression in *Vibrio cholerae*. Proc Natl Acad Sci U S A. 2002;99(5):3129-3134.

[39] Vance RE, Zhu J, Mekalanos JJ. A constitutively active variant of the quorum-sensing regulator LuxO affects protease production and biofilm formation in *Vibrio cholerae*. Infect Immun. 2003;71(5):2571-2576.

[40] Booth BA, Boesman-Finkelstein M, Finkelstein RA. *Vibrio cholerae* hemagglutinin/protease nicks cholera enterotoxin. Infect Immun. 1984;45(3): 558-560.

[41] Silva AJ, Leitch GJ, Camilli A, Benitez JA. Contribution of

hemagglutinin/protease and motility to the pathogenesis of El Tor biotype cholera. Infect Immun. 2006;74(4):2072-2079.

[42] Wu Z, Nybom P, Magnusson KE. Distinct effects of *Vibrio cholerae* haemagglutinin/protease on the structure and localization of the tight junctionassociated proteins occludin and ZO-1. Cell Microbiol. 2000;2(1):11-17.

[43] Finkelstein RA,

Boesman-Finkelstein M, Chang Y, Hase CC. *Vibrio cholerae* hemagglutinin/ protease, colonial variation, virulence, and detachment. Infect Immun. 1992; 60(2):472-478.

[44] Moustafa I, Connaris H, Taylor M, Zaitsev V, Wilson JC, Kiefel MJ, et al. Sialic acid recognition by *Vibrio cholerae* neuraminidase. J Biol Chem. 2004;279(39):40819-40826.

[45] Galen JE, Ketley JM, Fasano A, Richardson SH, Wasserman SS, Kaper JB. Role of *Vibrio cholerae* neuraminidase in the function of cholera toxin. Infect Immun. 1992;60(2):406-415.

[46] Crennell S, Garman E, Laver G, Vimr E, Taylor G. Crystal structure of *Vibrio cholerae* neuraminidase reveals dual lectin-like domains in addition to the catalytic domain. Structure. 1994; 2(6):535-544.

[47] Finkelstein RA, Mukerjee S, Rudra BC. Demonstration and Quantitation of Antigen in Cholera Stool Filtrates. J Infect Dis. 1963;113:99-104.

[48] Waldor MK, Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science. 1996;272(5270):1910-1914.

[49] Davis BM, Lawson EH, Sandkvist M, Ali A, Sozhamannan S, Waldor MK. Convergence of the secretory pathways for cholera toxin and the filamentous phage, CTXphi. Science. 2000;288(5464):333-335.

[50] Chaudhuri K. Structure, Genetics, and Mode of Disease of Cholera Toxin. In: Gopalakrishnakone P. B-MM, Llewellyn L., Singh B., editor. Biological Toxins and Bioterrorism. Toxinology. 1. Dordrecht: Springer; 2014. p. 3-27.

[51] Gadwal S, Korotkov KV, Delarosa JR, Hol WG, Sandkvist M. Functional and structural characterization of *Vibrio cholerae* extracellular serine protease B, VesB. J Biol Chem. 2014;289(12):8288-8298.

[52] Syngkon A, Elluri S, Koley H, Rompikuntal PK, Saha DR, Chakrabarti MK, et al. Studies on a novel serine protease of a DeltahapADeltaprtV *Vibrio cholerae* O1 strain and its role in hemorrhagic response in the rabbit ileal loop model. PLoS One. 2010;5(9).

[53] Vaitkevicius K, Rompikuntal PK, Lindmark B, Vaitkevicius R, Song T, Wai SN. The metalloprotease PrtV from *Vibrio cholerae*. FEBS J. 2008;275(12):3167-3177.

[54] Ogierman MA, Fallarino A, Riess T, Williams SG, Attridge SR, Manning PA. Characterization of the *Vibrio cholerae* El Tor lipase operon lipAB and a protease gene downstream of the hly region. J Bacteriol. 1997;179(22):7072-7080.

[55] Edwin A, Grundstrom C, Wai SN, Ohman A, Stier G, Sauer-Eriksson AE. Domain isolation, expression, purification and proteolytic activity of the metalloprotease PrtV from *Vibrio cholerae*. Protein Expr Purif. 2014;96:39-47.

[56] Rompikuntal PK, Vdovikova S, Duperthuy M, Johnson TL, Ahlund M, Lundmark R, et al. Outer Membrane Vesicle-Mediated Export of Processed PrtV Protease from *Vibrio cholerae*. PLoS One. 2015;10(7):e0134098.

[57] Vaitkevicius K, Lindmark B, Ou G, Song T, Toma C, Iwanaga M, et al. A *Vibrio cholerae* protease needed for

killing of Caenorhabditis elegans has a role in protection from natural predator grazing. Proc Natl Acad Sci U S A. 2006;103(24):9280-9285.

[58] Edwin A, Persson C, Mayzel M, Wai SN, Ohman A, Karlsson BG, et al. Structure of the N-terminal domain of the metalloprotease PrtV from *Vibrio cholerae*. Protein Sci. 2015;24(12): 2076-2080.

[59] Stoebner JA, Payne SM. Ironregulated hemolysin production and utilization of heme and hemoglobin by *Vibrio cholerae*. Infect Immun. 1988;56(11):2891-2895.

[60] Debellis L, Diana A, Arcidiacono D, Fiorotto R, Portincasa P, Altomare DF, et al. The *Vibrio cholerae* cytolysin promotes chloride secretion from intact human intestinal mucosa. PLoS One. 2009;4(3):e5074.

[61] Toma C, Honma Y. Cloning and genetic analysis of the *Vibrio cholerae* aminopeptidase gene. Infect Immun. 1996;64(11):4495-4500.

[62] Seper A, Hosseinzadeh A, Gorkiewicz G, Lichtenegger S, Roier S, Leitner DR, et al. *Vibrio cholerae* evades neutrophil extracellular traps by the activity of two extracellular nucleases. PLoS Pathog. 2013;9(9):e1003614.

[63] Blokesch M, Schoolnik GK. The extracellular nuclease Dns and its role in natural transformation of *Vibrio cholerae*. J Bacteriol. 2008;190(21):7232-7240.

[64] Joshi A, Kostiuk B, Rogers A, Teschler J, Pukatzki S, Yildiz FH. Rules of Engagement: The Type VI Secretion System in *Vibrio cholerae*. Trends Microbiol. 2017;25(4):267-279.

[65] Coulthurst S. The Type VI secretion system: a versatile bacterial weapon. Microbiology (Reading). 2019;165(5):503-515.

*The Secretome of* Vibrio cholerae *DOI: http://dx.doi.org/10.5772/intechopen.96803*

[66] Cherrak Y, Flaugnatti N, Durand E, Journet L, Cascales E. Structure and Activity of the Type VI Secretion System. Microbiol Spectr. 2019;7(4).

[67] Borgeaud S, Metzger LC, Scrignari T, Blokesch M. The type VI secretion system of *Vibrio cholerae* fosters horizontal gene transfer. Science. 2015;347(6217):63-67.

[68] Pukatzki S, Ma AT, Sturtevant D, Krastins B, Sarracino D, Nelson WC, et al. Identification of a conserved bacterial protein secretion system in *Vibrio cholerae* using the Dictyostelium host model system. Proc Natl Acad Sci U S A. 2006;103(5):1528-1533.

[69] Shneider MM, Buth SA, Ho BT, Basler M, Mekalanos JJ, Leiman PG. PAAR-repeat proteins sharpen and diversify the type VI secretion system spike. Nature. 2013;500(7462):350-353.

[70] Brunet YR, Henin J, Celia H, Cascales E. Type VI secretion and bacteriophage tail tubes share a common assembly pathway. EMBO Rep. 2014;15(3):315-321.

[71] Kube S, Kapitein N, Zimniak T, Herzog F, Mogk A, Wendler P. Structure of the VipA/B type VI secretion complex suggests a contraction-statespecific recycling mechanism. Cell Rep. 2014;8(1):20-30.

[72] Bonemann G, Pietrosiuk A, Diemand A, Zentgraf H, Mogk A. Remodelling of VipA/VipB tubules by ClpV-mediated threading is crucial for type VI protein secretion. EMBO J. 2009;28(4):315-325.

[73] Pietrosiuk A, Lenherr ED, Falk S, Bonemann G, Kopp J, Zentgraf H, et al. Molecular basis for the unique role of the AAA+ chaperone ClpV in type VI protein secretion. J Biol Chem. 2011;286(34):30010-30021.

[74] Unterweger D, Kostiuk B, Pukatzki S. Adaptor Proteins of Type VI Secretion System Effectors. Trends Microbiol. 2017;25(1):8-10.

[75] Crisan CV, Chande AT, Williams K, Raghuram V, Rishishwar L, Steinbach G, et al. Analysis of *Vibrio cholerae* genomes identifies new type VI secretion system gene clusters. Genome Biol. 2019;20(1):163.

[76] Labbate M, Orata FD, Petty NK, Jayatilleke ND, King WL, Kirchberger PC, et al. A genomic island in *Vibrio cholerae* with VPI-1 site-specific recombination characteristics contains CRISPR-Cas and type VI secretion modules. Sci Rep. 2016;6:36891.

[77] Unterweger D, Miyata ST, Bachmann V, Brooks TM, Mullins T, Kostiuk B, et al. The *Vibrio cholerae* type VI secretion system employs diverse effector modules for intraspecific competition. Nat Commun. 2014;5:3549.

[78] Dong TG, Mekalanos JJ. Characterization of the RpoN regulon reveals differential regulation of T6SS and new flagellar operons in *Vibrio cholerae* O37 strain V52. Nucleic Acids Res. 2012;40(16):7766-7775.

[79] Ishikawa T, Sabharwal D, Broms J, Milton DL, Sjostedt A, Uhlin BE, et al. Pathoadaptive conditional regulation of the type VI secretion system in *Vibrio cholerae* O1 strains. Infect Immun. 2012;80(2):575-584.

[80] Drebes Dorr NC, Blokesch M. Interbacterial competition and antipredatory behaviour of environmental *Vibrio cholerae* strains. Environ Microbiol. 2020;22(10):4485-4504.

[81] Yang X, Long M, Shen X. Effector(-) Immunity Pairs Provide the T6SS Nanomachine its Offensive and Defensive Capabilities. Molecules. 2018;23(5).

[82] Vettiger A, Basler M. Type VI Secretion System Substrates Are Transferred and Reused among Sister Cells. Cell. 2016;167(1):99-110 e12.

[83] Silverman JM, Agnello DM, Zheng H, Andrews BT, Li M, Catalano CE, et al. Haemolysin coregulated protein is an exported receptor and chaperone of type VI secretion substrates. Mol Cell. 2013;51(5):584-593.

[84] Williams SG, Varcoe LT, Attridge SR, Manning PA. *Vibrio cholerae* Hcp, a secreted protein coregulated with HlyA. Infect Immun. 1996;64(1):283-289.

[85] Pukatzki S, Ma AT, Revel AT, Sturtevant D, Mekalanos JJ. Type VI secretion system translocates a phage tail spike-like protein into target cells where it cross-links actin. Proc Natl Acad Sci U S A. 2007;104(39):15508-15513.

[86] Ma AT, Mekalanos JJ. In vivo actin cross-linking induced by *Vibrio cholerae* type VI secretion system is associated with intestinal inflammation. Proc Natl Acad Sci U S A. 2010;107(9):4365-4370.

[87] Brooks TM, Unterweger D, Bachmann V, Kostiuk B, Pukatzki S. Lytic activity of the *Vibrio cholerae* type VI secretion toxin VgrG-3 is inhibited by the antitoxin TsaB. J Biol Chem. 2013;288(11):7618-7625.

[88] Dong TG, Ho BT, Yoder-Himes DR, Mekalanos JJ. Identification of T6SSdependent effector and immunity proteins by Tn-seq in *Vibrio cholerae*. Proc Natl Acad Sci U S A. 2013;110(7): 2623-2628.

[89] Miyata ST, Kitaoka M, Brooks TM, McAuley SB, Pukatzki S. *Vibrio cholerae* requires the type VI secretion system virulence factor VasX to kill Dictyostelium discoideum. Infect Immun. 2011;79(7):2941-2949.

[90] Miyata ST, Unterweger D, Rudko SP, Pukatzki S. Dual expression profile of type VI secretion system immunity genes protects pandemic *Vibrio cholerae*. PLoS Pathog. 2013;9(12):e1003752.

[91] Kamal F, Liang X, Manera K, Pei TT, Kim H, Lam LG, et al. Differential Cellular Response to Translocated Toxic Effectors and Physical Penetration by the Type VI Secretion System. Cell Rep. 2020;31(11):107766.

[92] Altindis E, Dong T, Catalano C, Mekalanos J. Secretome analysis of *Vibrio cholerae* type VI secretion system reveals a new effector-immunity pair. mBio. 2015;6(2):e00075.

[93] Kostiuk B, Unterweger D, Provenzano D, Pukatzki S. T6SS intraspecific competition orchestrates *Vibrio cholerae* genotypic diversity. Int Microbiol. 2017;20(3):130-137.

[94] Kanonenberg K, Spitz O, Erenburg IN, Beer T, Schmitt L. Type I secretion system-it takes three and a substrate. FEMS Microbiol Lett. 2018;365(11).

[95] Gray L, Mackman N, Nicaud JM, Holland IB. The carboxy-terminal region of haemolysin 2001 is required for secretion of the toxin from Escherichia coli. Mol Gen Genet. 1986;205(1):127-133.

[96] Costa TR, Felisberto-Rodrigues C, Meir A, Prevost MS, Redzej A, Trokter M, et al. Secretion systems in Gram-negative bacteria: structural and mechanistic insights. Nat Rev Microbiol. 2015;13(6):343-359.

[97] Boardman BK, Satchell KJ. *Vibrio cholerae* strains with mutations in an atypical type I secretion system accumulate RTX toxin intracellularly. J Bacteriol. 2004;186(23):8137-8143.

[98] Boardman BK, Meehan BM, Fullner Satchell KJ. Growth phase regulation of *Vibrio cholerae* RTX toxin export. J Bacteriol. 2007;189(5):1827-1835.

[99] Linhartova I, Bumba L, Masin J, Basler M, Osicka R, Kamanova J, et al. RTX proteins: a highly diverse family secreted by a common

*The Secretome of* Vibrio cholerae *DOI: http://dx.doi.org/10.5772/intechopen.96803*

mechanism. FEMS Microbiol Rev. 2010;34(6):1076-1112.

[100] Lin W, Fullner KJ, Clayton R, Sexton JA, Rogers MB, Calia KE, et al. Identification of a *Vibrio cholerae* RTX toxin gene cluster that is tightly linked to the cholera toxin prophage. Proc Natl Acad Sci U S A. 1999;96(3):1071-1076.

[101] Cordero CL, Kudryashov DS, Reisler E, Satchell KJ. The Actin crosslinking domain of the *Vibrio cholerae* RTX toxin directly catalyzes the covalent cross-linking of actin. J Biol Chem. 2006;281(43):32366-32374.

[102] Cordero CL, Sozhamannan S, Satchell KJ. RTX toxin actin cross-linking activity in clinical and environmental isolates of *Vibrio cholerae*. J Clin Microbiol. 2007;45(7):2289-2292.

[103] Fullner KJ, Mekalanos JJ. In vivo covalent cross-linking of cellular actin by the *Vibrio cholerae* RTX toxin. EMBO J. 2000;19(20):5315-5323.

[104] Sheahan KL, Cordero CL, Satchell KJ. Identification of a domain within the multifunctional *Vibrio cholerae* RTX toxin that covalently crosslinks actin. Proc Natl Acad Sci U S A. 2004;101(26):9798-9803.

[105] Chatterjee R, Nag S, Chaudhuri K. Identification of a new RTX-like gene cluster in *Vibrio cholerae*. FEMS Microbiol Lett. 2008;284(2):165-171.

[106] Syed KA, Beyhan S, Correa N, Queen J, Liu J, Peng F, et al. The *Vibrio cholerae* flagellar regulatory hierarchy controls expression of virulence factors. J Bacteriol. 2009;191(21):6555-6570.

[107] Syed KA. Regulation of hemagglutinin by flagellar hierarchy in *Vibrio cholerae*. Ann Arbor: University of Texas; 2010.

[108] Kitts G, Giglio KM, Zamorano-Sanchez D, Park JH, Townsley L, Cooley RB, et al. A Conserved Regulatory Circuit Controls Large Adhesins in *Vibrio cholerae*. mBio. 2019;10(6).

[109] Miller KA, Tomberlin KF, Dziejman M. Vibrio variations on a type three theme. Curr Opin Microbiol. 2019;47:66-73.

[110] Chaand M, Miller KA, Sofia MK, Schlesener C, Weaver JW, Sood V, et al. Type 3 Secretion System Island Encoded Proteins Required for Colonization by Non-O1/non-O139 Serogroup *Vibrio cholerae*. Infect Immun. 2015;83(7): 2862-2869.

[111] Dziejman M, Serruto D, Tam VC, Sturtevant D, Diraphat P, Faruque SM, et al. Genomic characterization of non-O1, non-O139 *Vibrio cholerae* reveals genes for a type III secretion system. Proc Natl Acad Sci U S A. 2005;102(9):3465-3470.

[112] Shin OS, Tam VC, Suzuki M, Ritchie JM, Bronson RT, Waldor MK, et al. Type III secretion is essential for the rapidly fatal diarrheal disease caused by non-O1, non-O139 *Vibrio cholerae*. mBio. 2011;2(3):e00106-11.

[113] Portaliou AG, Tsolis KC, Loos MS, Zorzini V, Economou A. Type III Secretion: Building and Operating a Remarkable Nanomachine. Trends Biochem Sci. 2016;41(2):175-189.

[114] Alam A, Miller KA, Chaand M, Butler JS, Dziejman M. Identification of *Vibrio cholerae* type III secretion system effector proteins. Infect Immun. 2011;79(4):1728-1740.

[115] Morita M, Yamamoto S, Hiyoshi H, Kodama T, Okura M, Arakawa E, et al. Horizontal gene transfer of a genetic island encoding a type III secretion system distributed in *Vibrio cholerae*. Microbiol Immunol. 2013;57(5):334-339.

[116] Alam A, Tam V, Hamilton E, Dziejman M. vttRA and vttRB Encode ToxR family proteins that mediate bile-induced expression of type three secretion system genes in a non-O1/ non-O139 *Vibrio cholerae* strain. Infect Immun. 2010;78(6):2554-2570.

[117] Miller KA, Sofia MK, Weaver JWA, Seward CH, Dziejman M. Regulation by ToxR-Like Proteins Converges on vttRB Expression To Control Type 3 Secretion System-Dependent Caco2- BBE Cytotoxicity in *Vibrio cholerae*. J Bacteriol. 2016;198(11):1675-1682.

[118] Tam VC, Serruto D, Dziejman M, Brieher W, Mekalanos JJ. A type III secretion system in *Vibrio cholerae* translocates a formin/spire hybrid-like actin nucleator to promote intestinal colonization. Cell Host Microbe. 2007;1(2):95-107.

[119] Tam VC, Suzuki M, Coughlin M, Saslowsky D, Biswas K, Lencer WI, et al. Functional analysis of VopF activity required for colonization in *Vibrio cholerae*. mBio. 2010;1(5).

[120] Seward CH, Manzella A, Alam A, Butler JS, Dziejman M. Using S. cerevisiae as a Model System to Investigate V. cholerae VopX-Host Cell Protein Interactions and Phenotypes. Toxins (Basel). 2015;7(10):4099-4110.

[121] Suzuki M, Danilchanka O, Mekalanos JJ. *Vibrio cholerae* T3SS effector VopE modulates mitochondrial dynamics and innate immune signaling by targeting Miro GTPases. Cell Host Microbe. 2014;16(5):581-591.

[122] Kay LJ, Sangal V, Black GW, Soundararajan M. Proteomics and bioinformatics analyses identify novel cellular roles outside mitochondrial function for human miro GTPases. Mol Cell Biochem. 2019;451(1-2):21-35.

[123] Hospenthal MK, Costa TRD, Waksman G. A comprehensive guide to pilus biogenesis in Gramnegative bacteria. Nat Rev Microbiol. 2017;15(6):365-379.

[124] Lim MS, Ng D, Zong Z, Arvai AS, Taylor RK, Tainer JA, et al. *Vibrio cholerae* El Tor TcpA crystal structure and mechanism for pilus-mediated microcolony formation. Mol Microbiol. 2010;77(3):755-770.

[125] Kumar A, Das B, Kumar N. Vibrio Pathogenicity Island-1: The Master Determinant of Cholera Pathogenesis. Front Cell Infect Microbiol. 2020;10: 561296.

[126] Tacket CO, Taylor RK, Losonsky G, Lim Y, Nataro JP, Kaper JB, et al. Investigation of the roles of toxincoregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of *Vibrio cholerae* O139 infection. Infect Immun. 1998;66(2):692-695.

[127] Gutierrez-Rodarte M, Kolappan S, Burrell BA, Craig L. The *Vibrio cholerae* minor pilin TcpB mediates uptake of the cholera toxin phage CTXphi. J Biol Chem. 2019;294(43):15698-15710.

[128] Watnick PI, Fullner KJ, Kolter R. A role for the mannose-sensitive hemagglutinin in biofilm formation by *Vibrio cholerae* El Tor. J Bacteriol. 1999;181(11):3606-3609.

[129] Floyd KA, Lee CK, Xian W, Nametalla M, Valentine A, Crair B, et al. c-di-GMP modulates type IV MSHA pilus retraction and surface attachment in *Vibrio cholerae*. Nat Commun. 2020; 11(1):1549.

[130] Fullner KJ, Mekalanos JJ. Genetic characterization of a new type IV-A pilus gene cluster found in both classical and El Tor biotypes of *Vibrio cholerae*. Infect Immun. 1999;67(3):1393-1404.

[131] Adams DW, Stutzmann S, Stoudmann C, Blokesch M. DNA-uptake pili of *Vibrio cholerae* are required for chitin colonization and capable of kin recognition via sequence-specific selfinteraction. Nat Microbiol. 2019;4(9): 1545-1557.

#### *The Secretome of* Vibrio cholerae *DOI: http://dx.doi.org/10.5772/intechopen.96803*

[132] Shime-Hattori A, Iida T, Arita M, Park KS, Kodama T, Honda T. Two type IV pili of Vibrio parahaemolyticus play different roles in biofilm formation. FEMS Microbiol Lett. 2006;264(1):89-97.

[133] Ogura K, Yahiro K, Moss J. Cell Death Signaling Pathway Induced by Cholix Toxin, a Cytotoxin and eEF2 ADP-Ribosyltransferase Produced by *Vibrio cholerae*. Toxins (Basel). 2020;13(1).

[134] Jorgensen R, Purdy AE, Fieldhouse RJ, Kimber MS, Bartlett DH, Merrill AR. Cholix toxin, a novel ADPribosylating factor from *Vibrio cholerae*. J Biol Chem. 2008;283(16):10671-10678.

[135] Taverner A, MacKay J, Laurent F, Hunter T, Liu K, Mangat K, et al. Cholix protein domain I functions as a carrier element for efficient apical to basal epithelial transcytosis. Tissue Barriers. 2020;8(1):1710429.

[136] Trucksis M, Galen JE, Michalski J, Fasano A, Kaper JB. Accessory cholera enterotoxin (Ace), the third toxin of a *Vibrio cholerae* virulence cassette. Proc Natl Acad Sci U S A. 1993;90(11):5267-5271.

[137] Fasano A, Baudry B, Pumplin DW, Wasserman SS, Tall BD, Ketley JM, et al. *Vibrio cholerae* produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci U S A. 1991;88(12):5242-5246.

[138] Perez-Reytor D, Pavon A, Lopez-Joven C, Ramirez-Araya S, Pena-Varas C, Plaza N, et al. Analysis of the Zonula occludens Toxin Found in the Genome of the Chilean Nontoxigenic Vibrio parahaemolyticus Strain PMC53.7. Front Cell Infect Microbiol. 2020;10:482.

[139] Uzzau S, Cappuccinelli P, Fasano A. Expression of *Vibrio cholerae* zonula occludens toxin and analysis of its subcellular localization. Microb Pathog. 1999;27(6):377-385.

[140] Goldblum SE, Rai U, Tripathi A, Thakar M, De Leo L, Di Toro N, et al. The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation. FASEB J. 2011;25(1):144-158.

[141] Guerrero-Mandujano A, Hernandez-Cortez C, Ibarra JA, Castro-Escarpulli G. The outer membrane vesicles: Secretion system type zero. Traffic. 2017;18(7):425-432.

[142] Toyofuku M, Nomura N, Eberl L. Types and origins of bacterial membrane vesicles. Nat Rev Microbiol. 2019;17(1):13-24.

[143] Altindis E, Fu Y, Mekalanos JJ. Proteomic analysis of *Vibrio cholerae* outer membrane vesicles. Proc Natl Acad Sci U S A. 2014;111(15):E1548-E1556.

[144] Langlete P, Krabberod AK, Winther-Larsen HC. Vesicles From *Vibrio cholerae* Contain AT-Rich DNA and Shorter mRNAs That Do Not Correlate With Their Protein Products. Front Microbiol. 2019;10:2708.

[145] Sjostrom AE, Sandblad L, Uhlin BE, Wai SN. Membrane vesicle-mediated release of bacterial RNA. Sci Rep. 2015;5: 15329.

[146] Zingl FG, Kohl P, Cakar F, Leitner DR, Mitterer F, Bonnington KE, et al. Outer Membrane Vesiculation Facilitates Surface Exchange and In Vivo Adaptation of *Vibrio cholerae*. Cell Host Microbe. 2020;27(2):225-237 e8.

[147] Orench-Rivera N, Kuehn MJ. Environmentally controlled bacterial vesicle-mediated export. Cell Microbiol. 2016;18(11):1525-1536.

[148] Duperthuy M, Sjostrom AE, Sabharwal D, Damghani F, Uhlin BE, Wai SN. Role of the *Vibrio cholerae*

matrix protein Bap1 in cross-resistance to antimicrobial peptides. PLoS Pathog. 2013;9(10):e1003620.

[149] Miller VL, Mekalanos JJ. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in *Vibrio cholerae* requires toxR. J Bacteriol. 1988;170(6):2575-2583.

[150] Champion GA, Neely MN, Brennan MA, DiRita VJ. A branch in the ToxR regulatory cascade of *Vibrio cholerae* revealed by characterization of toxT mutant strains. Mol Microbiol. 1997;23(2):323-331.

[151] Mathur J, Waldor MK. The *Vibrio cholerae* ToxR-regulated porin OmpU confers resistance to antimicrobial peptides. Infect Immun. 2004;72(6):3577-3583.

[152] Blake PA, Weaver RE, Hollis DG. Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol. 1980;34:341-367.

[153] Aung KM, Sjostrom AE, von Pawel-Rammingen U, Riesbeck K, Uhlin BE, Wai SN. Naturally Occurring IgG Antibodies Provide Innate Protection against *Vibrio cholerae* Bacteremia by Recognition of the Outer Membrane Protein U. J Innate Immun. 2016;8(3):269-283.

[154] Reyes-Robles T, Dillard RS, Cairns LS, Silva-Valenzuela CA, Housman M, Ali A, et al. *Vibrio cholerae* Outer Membrane Vesicles Inhibit Bacteriophage Infection. J Bacteriol. 2018;200(15).

[155] Mah TF. Biofilm-specific antibiotic resistance. Future Microbiol. 2012;7(9): 1061-1072.

[156] Fong JNC, Yildiz FH. Biofilm Matrix Proteins. Microbiol Spectr. 2015;3(2).

[157] Chatterjee D, Chaudhuri K. Association of cholera toxin with *Vibrio*  *cholerae* outer membrane vesicles which are internalized by human intestinal epithelial cells. FEBS Lett. 2011;585(9):1357-1362.

[158] Rasti ES, Brown AC. Cholera Toxin Encapsulated within Several *Vibrio cholerae* O1 Serotype Inaba Outer Membrane Vesicles Lacks a Functional B-Subunit. Toxins (Basel). 2019;11(4).

[159] O'Donoghue EJ, Krachler AM. Mechanisms of outer membrane vesicle entry into host cells. Cell Microbiol. 2016;18(11):1508-1517.

[160] Mondal A, Tapader R, Chatterjee NS, Ghosh A, Sinha R, Koley H, et al. Cytotoxic and Inflammatory Responses Induced by Outer Membrane Vesicle-Associated Biologically Active Proteases from *Vibrio cholerae*. Infect Immun. 2016;84(5):1478-1490.

[161] Elluri S, Enow C, Vdovikova S, Rompikuntal PK, Dongre M, Carlsson S, et al. Outer membrane vesicles mediate transport of biologically active *Vibrio cholerae* cytolysin (VCC) from V. cholerae strains. PLoS One. 2014;9(9):e106731.

[162] Silva AJ, Benitez JA. *Vibrio cholerae* Biofilms and Cholera Pathogenesis. PLoS Negl Trop Dis. 2016;10(2):e0004330.

[163] Lutz C, Erken M, Noorian P, Sun S, McDougald D. Environmental reservoirs and mechanisms of persistence of *Vibrio cholerae*. Front Microbiol. 2013;4:375.

[164] Conner JG, Teschler JK, Jones CJ, Yildiz FH. Staying Alive: *Vibrio cholerae*'*s* Cycle of Environmental Survival, Transmission, and Dissemination. Microbiol Spectr. 2016;4(2).

[165] Echazarreta MA, Klose KE. Vibrio Flagellar Synthesis. Front Cell Infect Microbiol. 2019;9:131.

[166] Galan JE, Collmer A. Type III secretion machines: bacterial devices for *The Secretome of* Vibrio cholerae *DOI: http://dx.doi.org/10.5772/intechopen.96803*

protein delivery into host cells. Science. 1999;284(5418):1322-1328.

[167] Klose KE, Mekalanos JJ. Differential regulation of multiple flagellins in *Vibrio cholerae*. J Bacteriol. 1998;180(2):303-316.

[168] Dongre M, Singh B, Aung KM, Larsson P, Miftakhova R, Persson K, et al. Flagella-mediated secretion of a novel *Vibrio cholerae* cytotoxin affecting both vertebrate and invertebrate hosts. Commun Biol. 2018;1:59.

[169] Butler SM, Camilli A. Both chemotaxis and net motility greatly influence the infectivity of *Vibrio cholerae*. Proc Natl Acad Sci U S A. 2004;101(14):5018-5023.

[170] Utada AS, Bennett RR, Fong JCN, Gibiansky ML, Yildiz FH, Golestanian R, et al. *Vibrio cholerae* use pili and flagella synergistically to effect motility switching and conditional surface attachment. Nat Commun. 2014;5:4913.

[171] Lauriano CM, Ghosh C, Correa NE, Klose KE. The sodium-driven flagellar motor controls exopolysaccharide expression in *Vibrio cholerae*. J Bacteriol. 2004;186(15):4864-4874.

[172] Yildiz F, Fong J, Sadovskaya I, Grard T, Vinogradov E. Structural characterization of the extracellular polysaccharide from *Vibrio cholerae* O1 El-Tor. PLoS One. 2014;9(1):e86751.

[173] Yildiz FH, Schoolnik GK. *Vibrio cholerae* O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation. Proc Natl Acad Sci U S A. 1999;96(7):4028-4033.

[174] Fong JCN, Syed KA, Klose KE, Yildiz FH. Role of Vibrio polysaccharide (vps) genes in VPS production, biofilm formation and *Vibrio cholerae* pathogenesis. Microbiology (Reading). 2010;156(Pt 9):2757-2769.

[175] Schwechheimer C, Hebert K, Tripathi S, Singh PK, Floyd KA, Brown ER, et al. A tyrosine phosphoregulatory system controls exopolysaccharide biosynthesis and biofilm formation in *Vibrio cholerae*. PLoS Pathog. 2020;16(8):e1008745.

[176] Teschler JK, Zamorano-Sanchez D, Utada AS, Warner CJ, Wong GC, Linington RG, et al. Living in the matrix: assembly and control of *Vibrio cholerae* biofilms. Nat Rev Microbiol. 2015;13(5):255-268.

[177] Fong JC, Yildiz FH. The rbmBCDEF gene cluster modulates development of rugose colony morphology and biofilm formation in *Vibrio cholerae*. J Bacteriol. 2007;189(6):2319-2330.

[178] Kaus K, Biester A, Chupp E, Lu J, Visudharomn C, Olson R. The 1.9 A crystal structure of the extracellular matrix protein Bap1 from *Vibrio cholerae* provides insights into bacterial biofilm adhesion. J Biol Chem. 2019;294(40):14499-14511.

[179] Fong JC, Karplus K, Schoolnik GK, Yildiz FH. Identification and characterization of RbmA, a novel protein required for the development of rugose colony morphology and biofilm structure in *Vibrio cholerae*. J Bacteriol. 2006;188(3):1049-1059.

[180] Smith DR, Maestre-Reyna M, Lee G, Gerard H, Wang AH, Watnick PI. In situ proteolysis of the *Vibrio cholerae* matrix protein RbmA promotes biofilm recruitment. Proc Natl Acad Sci U S A. 2015;112(33):10491-10496.

[181] Duperthuy M, Uhlin BE, Wai SN. Biofilm recruitment of *Vibrio cholerae* by matrix proteolysis. Trends Microbiol. 2015;23(11):667-668.

[182] Absalon C, Van Dellen K, Watnick PI. A communal bacterial adhesin anchors biofilm and bystander cells to surfaces. PLoS Pathog. 2011;7(8): e1002210.

[183] Vorkapic D, Pressler K, Schild S. Multifaceted roles of extracellular DNA in bacterial physiology. Curr Genet. 2016;62(1):71-79.

[184] Kanampalliwar A, Singh DV. Extracellular DNA builds and interacts with vibrio polysaccharide in the biofilm matrix formed by *Vibrio cholerae*. Environ Microbiol Rep. 2020;12(5):594-606.

[185] Seper A, Fengler VH, Roier S, Wolinski H, Kohlwein SD, Bishop AL, et al. Extracellular nucleases and extracellular DNA play important roles in *Vibrio cholerae* biofilm formation. Mol Microbiol. 2011;82(4):1015-1037.

[186] Kaplan JB. Biofilm dispersal: mechanisms, clinical implications, and potential therapeutic uses. J Dent Res. 2010;89(3):205-218.

[187] Singh PK, Bartalomej S, Hartmann R, Jeckel H, Vidakovic L, Nadell CD, et al. *Vibrio cholerae* Combines Individual and Collective Sensing to Trigger Biofilm Dispersal. Curr Biol. 2017;27(21):3359-3366 e7.

[188] Bridges AA, Fei C, Bassler BL. Identification of signaling pathways, matrix-digestion enzymes, and motility components controlling *Vibrio cholerae* biofilm dispersal. Proc Natl Acad Sci U S A. 2020;117(51):32639-32647.

[189] Mewborn L, Benitez JA, Silva AJ. Flagellar motility, extracellular proteases and *Vibrio cholerae* detachment from abiotic and biotic surfaces. Microb Pathog. 2017;113:17-24.
